Set Analyses:
Advanced Search

Advanced Search

Search By
Section (entire)

or upload a file of gene symbols

Category   Symbol Source: HGNC EntrezGene Ensembl GeneCards RNA genes CroW21

CYP24A1 Gene

protein-coding   GIFtS: 69
GCID: GC20M052769

Cytochrome P450, Family 24, Subfamily A, Polypeptide 1

(Previous names: cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase))
(Previous symbol: CYP24)
  See related diseases

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

Cytochrome P450, Family 24, Subfamily A, Polypeptide 11 2     1,25-Dihydroxyvitamin D(3) 24-Hydroxylase, Mitochondrial2
CYP241 2 3 5     CP242
Cytochrome P450, Subfamily XXIV (Vitamin D 24-Hydroxylase)1 2     HCAI2
Cytochrome P450 24A12 3     P450-CC242
Cytochrome P450-CC242 3     Exo-Mitochondrial Protein2
Vitamin D(3) 24-Hydroxylase2 3     Vitamin D 24-Hydroxylase2
24-OHase2 3     EC
1,25-@Dihydroxyvitamin D3 24-Hydroxylase2     

External Ids:    HGNC: 26021   Entrez Gene: 15912   Ensembl: ENSG000000191867   OMIM: 1260655   UniProtKB: Q079733   

Export aliases for CYP24A1 gene to outside databases

Previous GC identifers: GC20M052458 GC20M053408 GC20M053455 GC20M052203 GC20M049516

(According to Entrez Gene, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

Entrez Gene summary for CYP24A1 Gene:
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are
monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids
and other lipids. This mitochondrial protein initiates the degradation of 1,25-dihydroxyvitamin D3, the
physiologically active form of vitamin D3, by hydroxylation of the side chain. In regulating the level of vitamin
D3, this enzyme plays a role in calcium homeostasis and the vitamin D endocrine system. Alternatively spliced
transcript variants encoding different isoforms have been found for this gene. (provided by RefSeq, Jul 2008)

GeneCards Summary for CYP24A1 Gene: 
CYP24A1 (cytochrome P450, family 24, subfamily A, polypeptide 1) is a protein-coding gene. Diseases associated with CYP24A1 include hypercalcemia, infantile, and osteomalacia, and among its related super-pathways are Vitamin D2 (ergocalciferol) metabolism and Cytochrome P450 - arranged by substrate type. GO annotations related to this gene include electron carrier activity and heme binding. An important paralog of this gene is CYP11A1.

UniProtKB/Swiss-Prot: CP24A_HUMAN, Q07973
Function: Has a role in maintaining calcium homeostasis. Catalyzes the NADPH-dependent 24-hydroxylation of
calcidiol (25-hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin D(3)). The enzyme can perform up
to 6 rounds of hydroxylation of calcitriol leading to calcitroic acid. It also shows 23-hydroxylating activity
leading to 1-alpha,25-dihydroxyvitamin D(3)-26,23-lactone as end product

Gene Wiki entry for CYP24A1 Gene

(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 73), Regulatory elements and Epigenetics data according to QIAGEN, SABiosciences, and/or SwitchGear Genomics)
About This Section
RefSeq DNA sequence:
NC_000020.10  NT_011362.10  NC_018931.2  
Regulatory elements:
   SABiosciences Regulatory transcription factor binding sites in the CYP24A1 gene promoter:
         AML1a   AP-1   ATF-2   FOXD3   YY1   C/EBPalpha   CREB   AREB6   deltaCREB   c-Jun   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmidCYP24A1 promoter sequence
   Search SABiosciences Chromatin IP Primers for CYP24A1

QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat CYP24A1

Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 20q13   Ensembl cytogenetic band:  20q13.2   HGNC cytogenetic band: 20q13.2-q13.3

CYP24A1 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
CYP24A1 gene location

GeneLoc information about chromosome 20         GeneLoc Exon Structure

GeneLoc location for GC20M052769:  view genomic region     (about GC identifiers)

52,769,988 bp from pter      End:
52,790,516 bp from pter
20,529 bases      Orientation:
minus strand

(According to UniProtKB, HORDE, neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MAXQB RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Cloud-Clone Corp.,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Cloud-Clone Corp., Ontologies according to Gene Ontology Consortium 01 Oct 2013 and Entrez Gene, Antibodies by EMD Millipore, R&D Systems, GenScript, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, and/or Cloud-Clone Corp.)
About This Section

UniProtKB/Swiss-Prot: CP24A_HUMAN, Q07973 (See protein sequence)
Recommended Name: 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial precursor  
Size: 514 amino acids; 58875 Da
Cofactor: Heme group (By similarity)
Subcellular location: Mitochondrion
Secondary accessions: Q15807 Q32ML3
Alternative splicing: 2 isoforms:  Q07973-1   Q07973-2   (No experimental confirmation available)

Explore the universe of human proteins at neXtProt for CYP24A1: NX_Q07973

Explore proteomics data for CYP24A1 at MOPED 

Post-translational modifications:

  • View modification sites using PhosphoSitePlus
  • View neXtProt modification sites for NX_Q07973

  • CYP24A1 Protein expression data from MOPED1, PaxDb2 and MAXQB3 :    About this image 

    CYP24A1 Protein Expression
    REFSEQ proteins (2 alternative transcripts): 
    NP_000773.2  NP_001122387.1  

    ENSEMBL proteins: 
     ENSP00000216862   ENSP00000379285   ENSP00000379284  
    Reactome Protein details: Q07973
    Human Recombinant Protein Products for CYP24A1: 
    Browse Purified and Recombinant Proteins at EMD Millipore
    Browse R&D Systems for human recombinant proteins
    Browse recombinant and purified proteins available from Enzo Life Sciences
    Browse OriGene full length recombinant human proteins expressed in human HEK293 cells
    Browse OriGene Protein Over-expression Lysates
    OriGene Custom MassSpec 
    OriGene Custom Protein Services for CYP24A1
    GenScript Custom Purified and Recombinant Proteins Services for CYP24A1
    Novus Biologicals CYP24A1 Protein
    Browse Sino Biological Recombinant Proteins
    Browse Sino Biological Cell Lysates 
    Browse ProSpec Recombinant Proteins
    Cloud-Clone Corp. Proteins for CYP24A1 

    Gene Ontology (GO): 2 cellular component terms (GO ID links to tree view):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005739mitochondrion ----
    GO:0005743mitochondrial inner membrane TAS--

    CYP24A1 for ontologies           About GeneDecksing

    CYP24A1 Antibody Products: 
    EMD Millipore Mono- and Polyclonal Antibodies for the study of CYP24A1
    Browse R&D Systems for Antibodies
    OriGene Antibodies for CYP24A1
    OriGene Custom Antibody Services for CYP24A1
    GenScript Custom Superior Antibodies Services for CYP24A1
    Novus Biologicals CYP24A1 Antibodies
    Abcam antibodies for CYP24A1
    Cloud-Clone Corp. Antibodies for CYP24A1 
    ThermoFisher Antibodies for CYP24A1
    LSBio Antibodies in human, mouse, rat for CYP24A1 

    Assay Products for CYP24A1: 
    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Assay Services for CYP24A1
    Browse R&D Systems for biochemical assays
    GenScript Custom Assay Services for CYP24A1
    Browse Enzo Life Sciences for kits & assays
    Cloud-Clone Corp. ELISAs for CYP24A1 
    Cloud-Clone Corp. CLIAs for CYP24A1

    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section
    HGNC Gene Families: 
    CYP: Cytochrome P450s

    IUPHAR Guide to PHARMACOLOGY protein family classification: CYP24A1 
    CYP24, CYP26 and CYP27 families

    3 InterPro protein domains:
     IPR001128 Cyt_P450
     IPR017972 Cyt_P450_CS
     IPR002401 Cyt_P450_E_grp-I

    Graphical View of Domain Structure for InterPro Entry Q07973

    ProtoNet protein and cluster: Q07973

    1 Blocks protein domain: IPB002949 CC24 mitochondrial P450 signature

    UniProtKB/Swiss-Prot: CP24A_HUMAN, Q07973
    Similarity: Belongs to the cytochrome P450 family

    CYP24A1 for domains           About GeneDecksing

    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    bound targets from SABiosciences, miRNA Gene Targets from miRTarBase, shRNA from OriGene, RNAi from EMD Millipore, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, Gene Editing from DNA2.0, Sirion Biotech, Clones from EMD Millipore, OriGene, SwitchGear Genomics, GenScript, Sino Biological, DNA2.0, Vector BioLabs, and Sirion Biotech, Cell Lines from GenScript, LifeMap BioReagents, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene.)
    About This Section

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: CP24A_HUMAN, Q07973
    Function: Has a role in maintaining calcium homeostasis. Catalyzes the NADPH-dependent 24-hydroxylation of
    calcidiol (25-hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin D(3)). The enzyme can perform up
    to 6 rounds of hydroxylation of calcitriol leading to calcitroic acid. It also shows 23-hydroxylating activity
    leading to 1-alpha,25-dihydroxyvitamin D(3)-26,23-lactone as end product
    Catalytic activity: Calcitriol + NADPH + O(2) = calcitetrol + NADP(+) + H(2)O
    Catalytic activity: Calcidiol + NADPH + O(2) = secalciferol + NADP(+) + H(2)O

         Enzyme Number (IUBMB): EC

         Gene Ontology (GO): 5/8 molecular function terms (GO ID links to tree view) (see all 8):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0004497monooxygenase activity ----
    GO:0005506iron ion binding IEA--
    GO:000840325-hydroxycholecalciferol-24-hydroxylase activity IEA--
    GO:0009055electron carrier activity IEA--
    GO:0016491oxidoreductase activity NAS7632726
    CYP24A1 for ontologies           About GeneDecksing

         1 GenomeRNAi human phenotype for CYP24A1:
     Cell cycle / mitosis defect 

         6 MGI mutant phenotypes (inferred from 1 allele(MGI details for Cyp24a1):
     growth/size  homeostasis/metabolism  mortality/aging  renal/urinary system  reproductive system 

    CYP24A1 for phenotypes           About GeneDecksing

    Animal Models:
         MGI mouse knock-out Cyp24a1tm1Star for CYP24A1

       inGenious Targeting Laboratory - Custom generated mouse model solutions for CYP24A1 
       inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for CYP24A1

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for CYP24A1 
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for CYP24A1 

    miRTarBase miRNAs that target CYP24A1:
    hsa-mir-125b (MIRT004408)

    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat CYP24A1
    8/16 QIAGEN miScript miRNA Assays for microRNAs that regulate CYP24A1 (see all 16):
    hsa-miR-3671 hsa-miR-30c hsa-miR-125a-5p hsa-miR-571 hsa-miR-30d hsa-miR-3144-3p hsa-miR-374a* hsa-miR-144
    SwitchGear 3'UTR luciferase reporter plasmidCYP24A1 3' UTR sequence
    Inhib. RNA
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for CYP24A1
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat CYP24A1

    Gene Editing
    DNA2.0 Custom Protein Engineering Service for CYP24A1
    Sirion Biotech Customized adenovirus for overexpression of CYP24A1

    Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
    OriGene clones in human, mouse for CYP24A1 (see all 7)
    OriGene ORF clones in mouse, rat for CYP24A1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector (see all 2): CYP24A1 (NM_000782)
    Browse Sino Biological Human cDNA Clones
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for CYP24A1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat CYP24A1
    Sirion Biotech Customized lentivirus for stable overexpression of CYP24A1 
                         Customized lentivirus expression plasmids for stable overexpression of CYP24A1 

    Cell Line
    GenScript Custom overexpressing Cell Line Services for CYP24A1
    Search LifeMap BioReagents cell lines for CYP24A1
    In Situ Assay

    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for CYP24A1

    (Pathways according to EMD Millipore, R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to SABiosciences, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Oct 2013 via Entrez Gene).
    About This Section

    SuperPaths for CYP24A1 About   (see all 9)                                                                                              See pathways by source

    SuperPathContained pathways About
    1Vitamin D2 (ergocalciferol) metabolism
    Vitamin D2 (ergocalciferol) metabolism0.40
    Vitamin D (calciferol) metabolism0.36
    Vitamin D synthesis0.40
    2Cytochrome P450 - arranged by substrate type
    Cytochrome P450 - arranged by substrate type0.75
    Phase 1 - Functionalization of compounds0.74
    cytochrome P4500.75
    Metabolism of lipids and lipoproteins0.34
    Metabolic pathways0.40
    4Biological oxidations
    Biological oxidations0.55
    metapathway biotransformation0.41
    5Metabolism of steroid hormones and vitamin D
    Metabolism of steroid hormones and vitamin D1.00
    Steroid hormones1.00

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways

    2 EMD Millipore Pathways for CYP24A1
        Transcription Role of VDR in regulation of genes involved in osteoporosis
    Vitamin D2 (ergocalciferol) metabolism

    2 GeneGo (Thomson Reuters) Pathways for CYP24A1
        Transcription Role of VDR in regulation of genes involved in osteoporosis
    Vitamin D2 (ergocalciferol) metabolism

    4 BioSystems Pathways for CYP24A1
        Vitamin D synthesis
    cytochrome P450
    Nuclear receptors in lipid metabolism and toxicity
    metapathway biotransformation

    5/9        Reactome Pathways for CYP24A1 (see all 9)
        Cytochrome P450 - arranged by substrate type
    Steroid hormones
    Vitamin D (calciferol) metabolism
    Metabolism of steroid hormones and vitamin D

    3         Kegg Pathways  (Kegg details for CYP24A1):
        Steroid biosynthesis
    Metabolic pathways
    MicroRNAs in cancer

    CYP24A1 for pathways           About GeneDecksing


        SABiosciences Gene Network CentralTM Interacting Genes and Proteins Network for CYP24A1

    STRING Interaction Network Preview (showing 4 interactants - click image to see more details)

    5/6 Interacting proteins for CYP24A1 (Q079732, 3 ENSP000002168624) via UniProtKB, MINT, STRING, and/or I2D (see all 6)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    CITED1Q999663, ENSP000003885484I2D: score=1 STRING: ENSP00000388548
    TP53P046373, ENSP000002693054I2D: score=1 STRING: ENSP00000269305
    VDRP114733, ENSP000002290224I2D: score=1 STRING: ENSP00000229022
    TARBP2Q156333I2D: score=2 
    UBCENSP000003448184STRING: ENSP00000344818
    About this table

    Gene Ontology (GO): 5/10 biological process terms (GO ID links to tree view) (see all 10):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0001649osteoblast differentiation IEP17023519
    GO:0006766vitamin metabolic process TAS--
    GO:0006805xenobiotic metabolic process TAS--
    GO:0008202steroid metabolic process TAS--
    GO:0033280response to vitamin D IDA16720713

    CYP24A1 for ontologies           About GeneDecksing

    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB, with drugs/clinical trials/news search links to CenterWatch)
    About This Section

    CYP24A1 for compounds           About GeneDecksing

    Browse Small Molecules at EMD Millipore
    Browse drugs & compounds from Enzo Life Sciences

    Browse Tocris compounds for CYP24A1 (CP24A)

    9 HMDB Compounds for CYP24A1    About this table
    CompoundSynonyms CAS #PubMed Ids
    Calcidiol25-Hydroxyvitamin D3 (see all 11)19356-17-3--
    Calcitriol(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol (see all 19)32222-06-3--
    CalciumCa (see all 2)7440-70-2--
    Ercalcitriol1,25-Dihydroxycalciferol (see all 7)60133-18-8--
    Ergocalciferol(+)-Vitamin D2 (see all 72)50-14-6--
    Heme(protoporphyrinato)iron (see all 19)14875-96-8--
    NADPAdenine-nicotinamide dinucleotide phosphate (see all 18)53-59-8--
    NADPH2'-(dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) Adenosine 5'-ester with 1,4-dihydro-1-b-D-ribofuranosylnicotinamide (see all 23)53-57-6--
    Vitamin D3(+)-Vitamin D3 (see all 32)67-97-0--

    6 DrugBank Compounds for CYP24A1    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    ErgocalciferolSynthetic Vitamin D (see all 2)50-14-6enzymesubstrate15574355 15764712 16816472 11686044 16516540
    Calcitriol1,25-(OH)2D3 (see all 2)32222-06-3enzymesubstrate inducer20619365 19934256
    CalcidiolCalcifediol (see all 4)19356-17-3enzymesubstrate19934256
    Calcipotriol-- 112965-21-6enzymesubstrate16886668
    CorticotropinACTH (see all 5)9002-60-2enzymeinducer19920212
    Paricalcitol-- 131918-61-1enzymesubstrate15733015

    10/29 Novoseek inferred chemical compound relationships for CYP24A1 gene (see all 29)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    calcitroic acid 91.3 5 11686044 (1), 15574355 (1), 17646648 (1), 16816472 (1) (see all 5)
    vitamin d 90.9 152 11179754 (4), 19237542 (3), 14760115 (3), 14648702 (2) (see all 81)
    calcitriol 90.9 96 17368180 (6), 16708384 (4), 12027461 (4), 12914530 (3) (see all 40)
    1,25 dihydroxy vitamin d3 90.6 38 15225756 (3), 16457885 (2), 19922790 (2), 15836435 (2) (see all 24)
    25-hydroxyvitamin d 89.7 42 11686044 (2), 16600026 (2), 11012668 (2), 17395559 (2) (see all 27)
    1,24,25-trihydroxyvitamin d3 88.2 3 12504896 (1), 9165006 (1)
    bm 15766 82.5 4 16598763 (2), 16824767 (2)
    24,25-dihydroxyvitamin d3 82.3 3 12504896 (1), 9165006 (1)
    paricalcitol 69.8 1 16371233 (1)
    7-dehydrocholesterol 61.5 3 16598763 (1), 16824767 (1)

    Search CenterWatch for drugs/clinical trials and news about CYP24A1 / CP24A

    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    Conferences by KenesGroup, exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    RNAi Products from EMD Millipore,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN,
    Tagged/untagged cDNA clones from OriGene, SwitchGear Genomics, GenScript, DNA2.0, Vector BioLabs, Sirion Biotech, Primers from OriGene, SABiosciences, and/or QIAGEN )
    About This Section

    REFSEQ mRNAs for CYP24A1 gene (2 alternative transcripts): 
    NM_000782.4  NM_001128915.1  

    Unigene Cluster for CYP24A1:

    Cytochrome P450, family 24, subfamily A, polypeptide 1
    Hs.89663  [show with all ESTs]
    Unigene Representative Sequence: NM_000782
    6 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000216862(uc002xwu.1 uc002xwv.2 uc002xww.2) ENST00000395955
    ENST00000460643 ENST00000395954 ENST00000487593 ENST00000472970
    QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat CYP24A1
    8/16 QIAGEN miScript miRNA Assays for microRNAs that regulate CYP24A1 (see all 16):
    hsa-miR-3671 hsa-miR-30c hsa-miR-125a-5p hsa-miR-571 hsa-miR-30d hsa-miR-3144-3p hsa-miR-374a* hsa-miR-144
    SwitchGear 3'UTR luciferase reporter plasmidCYP24A1 3' UTR sequence
    Inhib. RNA
    Browse for Gene Knock-down Tools from EMD Millipore
    OriGene RNAi products in human, mouse, rat for CYP24A1
    QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat CYP24A1
    OriGene clones in human, mouse for CYP24A1 (see all 7)
    OriGene ORF clones in mouse, rat for CYP24A1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector (see all 2): CYP24A1 (NM_000782)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for CYP24A1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat CYP24A1
    Sirion Biotech Customized lentivirus for stable overexpression of CYP24A1 
                         Customized lentivirus expression plasmids for stable overexpression of CYP24A1 
    OriGene qPCR primer pairs and template standards for CYP24A1
    OriGene qSTAR qPCR primer pairs in human, mouse for CYP24A1
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat CYP24A1
      QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat CYP24A1
      QIAGEN QuantiFast Probe-based Assays in human, mouse, rat CYP24A1

    Additional mRNA sequence: 

    AY858838.1 BC109083.1 BC109084.1 L13286.1 S67623.1 

    6 DOTS entries:

    DT.99972261  DT.91986788  DT.75108883  DT.311476  DT.75100645  DT.91696137 

    24/29 AceView cDNA sequences (see all 29):

    BM928702 AA877213 AW205073 N20655 BX109503 AW194692 AW206049 BU662901 
    CD013988 S67623 BF800401 BG401173 N29030 AW237530 NM_000782 L13286 
    BF356900 AI400154 N21576 AI928330 BI491491 N30976 H82378 AW022457 

    GeneLoc Exon Structure

    5/6 Alternative Splicing Database (ASD) splice patterns (SP) for CYP24A1 (see all 6)    About this scheme

    ExUns: 1a · 1b · 1c ^ 2a · 2b ^ 3a · 3b ^ 4 ^ 5 ^ 6a · 6b ^ 7a · 7b ^ 8 ^ 9 ^ 10 ^ 11a · 11b ^ 12a · 12b · 12c · 12d
    SP1:                          -     -                                         -                       -           -                     
    SP2:                          -     -                                         -                 -     -           -                     
    SP3:                                                                          -                       -           -                     

    ECgene alternative splicing isoforms for CYP24A1

    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, plus additional links to Genevestigator, and/or SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from SABiosciences, Primers from OriGene, SABiosciences, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    CYP24A1 expression in normal human tissues (normalized intensities)      CYP24A1 embryonic expression: see
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    CYP24A1 Expression
    About this image

    CYP24A1 expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database 
     5/6 selected tissues (see all 6) fully expand
     Eye (Sensory Organs)    fully expand to see all 4 entries
             Human corneal endothelial cells
             Human Retinal Pigment Epithelial Cells (HRPEpiC)   
             retinal progenitor cell e16.5   
             tonsil epithelium   
     Endothelium (Cardiovascular System)
             Human corneal endothelial cells
     Epithelium (Uncategorized)
             tonsil epithelium   
     Kidney (Urinary System)

    See CYP24A1 Protein Expression from SPIRE MOPED and PaxDB
    Genevestigator expression for CYP24A1

    SOURCE GeneReport for Unigene cluster: Hs.89663
        SABiosciences Expression via Pathway-Focused PCR Array including CYP24A1: 
              Drug Metabolism: Phase I Enzymes in human mouse rat

    OriGene qPCR primer pairs and template standards for CYP24A1
    OriGene qSTAR qPCR primer pairs in human, mouse for CYP24A1
    SABiosciences RT2 qPCR Primer Assay in human, mouse, rat CYP24A1
    QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat CYP24A1
    QIAGEN QuantiFast Probe-based Assays in human, mouse, rat CYP24A1
    In Situ
    Assay Products:

    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for CYP24A1

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    This gene was present in the common ancestor of animals.

    Orthologs for CYP24A1 gene from 6/13 species (see all 13)    About this table
    Organism Taxonomic
    Gene Description Human
    (Mus musculus)
    Mammalia Cyp24a11 , 5 cytochrome P450, family 24, subfamily a, polypeptide more1, 5 81.06(n)1
      2 (91.91 cM)5
    130811  NM_009996.31  NP_034126.11 
    (Gallus gallus)
    Aves CYP24A11 cytochrome P450, family 24, subfamily A, polypeptide more 70.93(n)
      395827  NM_204979.1  NP_990310.1 
    (Anolis carolinensis)
    Reptilia --
    Uncharacterized protein
    1 ↔ many
    1 ↔ many
    (Danio rerio)
    Actinopterygii cyp24a11 cytochrome P450, family 24, subfamily A, polypeptide more 66.59(n)
      100004700  NM_001089458.1  NP_001082927.1 
    fruit fly
    (Drosophila melanogaster)
    Insecta Cyp12b21 CG15077-PA 43.46(n)
      37163  NM_137526.3  NP_611370.2 
    (Caenorhabditis elegans)
    Secernentea cyp-44A11 Protein CYP-44A1 41.76(n)
      173936  NM_062651.2  NP_495052.1 

    ENSEMBL Gene Tree for CYP24A1 (if available)
    TreeFam Gene Tree for CYP24A1 (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to Build 68)
    About This Section
    Paralogs for CYP24A1 gene
    CYP11A12  CYP27A12  CYP11B12  CYP27C12  CYP11B22  CYP27B12  
    6 SIMAP similar genes for CYP24A1 using alignment to 1 protein entry:     CP24A_HUMAN:
    CYP24    CYP27C1    CYP27A1    CYP11B2    CYP11B1    CYP27B1

    CYP24A1 for paralogs           About GeneDecksing

    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD) and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers from QIAGEN, Cancer Mutation PCR Arrays and Assays and Copy Number PCR Arrays from SABiosciences)
    About This Section

    10/711 SNPs in CYP24A1 are shown (see all 711)    About this table     
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    Chr 20 posSequence#AA
    Hypercalcemia infantile (HCAI)4--see VAR_0664092 R Q mis40--------
    Hypercalcemia infantile (HCAI)4--see VAR_0664102 E K mis40--------
    C,F,HHypercalcemia infantile (HCAI)4 --52744604(+) TGGGTA/GAAGCA 4 S L mis113Minor allele frequency- G:0.00NS EA NA MN EU 6785
    C,FHypercalcemia infantile (HCAI)4 --52744644(+) AGTCCG/AAGTTG 4 /R /W mis12Minor allele frequency- A:0.00NA 4724
    C--49516610(+) AAGAC-/ATGTGAA 2 -- ut316Minor allele frequency- AT:0.27EU EA NA MN CSA 432
    C--49519007(+) TGTTA-/ATTTAA 2 -- int10--------
    C,F--49531771(+) CTTCTT/CTATTT 2 -- int13Minor allele frequency- C:0.17WA NA EA 358
    C--49531773(+) TCTTTC/ATTTCT 2 -- int16Minor allele frequency- A:0.49WA CSA NA EA 362
    --49531816(+) CCTTCC/GCTCCT 2 -- int10--------
    C,H--49531905(+) cttccC/Ttccct 2 -- int1 trp30--------

    HapMap Linkage Disequilibrium report for CYP24A1 (52769988 - 52790516 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 5 variations for CYP24A1:    About this table     
    Variant IDTypeSubtypePubMed ID
    esv28399CNV Loss19812545
    nsv912946CNV Loss21882294
    nsv912945CNV Loss21882294
    nsv834010CNV Loss17160897
    esv259753OTHER Complex20981092

    Human Gene Mutation Database (HGMD): CYP24A1
    SABiosciences Cancer Mutation PCR Assays
    SeqTarget long-range PCR primers for resequencing CYP24A1
    DNA2.0 Custom Variant and Variant Library Synthesis for CYP24A1

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Conferences by KenesGroup, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section
    OMIM gene information: 126065    OMIM disorders: --

    UniProtKB/Swiss-Prot: CP24A_HUMAN, Q07973
  • Hypercalcemia infantile (HCAI) [MIM:143880]: A disorder characterized by abnormally high level of calcium
    in the blood, failure to thrive, vomiting, dehydration, and nephrocalcinosis. Note=The disease is caused by
    mutations affecting the gene represented in this entry

  • 20/40 diseases for CYP24A1 (see all 40):    About MalaCards
    hypercalcemia, infantile    osteomalacia    rickets    cytochrome p450
    hypercalcemia    nephrocalcinosis    gigantism    renal clear cell carcinoma
    rabies    osteosarcoma    esophageal adenocarcinoma    colon cancer
    lung adenocarcinoma    basal cell carcinoma    esophageal cancer    thyroid cancer
    myeloid leukemia    endometriosis    type 1 diabetes    prostate cancer

    1 disease from the University of Copenhagen DISEASES database for CYP24A1:

    CYP24A1 for disorders           About GeneDecksing

    10/24 Novoseek inferred disease relationships for CYP24A1 gene (see all 24)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    rickets 64 2 8266831 (1), 15544953 (1)
    rickets hypophosphatemic 57.8 1 16753019 (1)
    prostate cancer 40.2 15 12270218 (2), 12485911 (2), 17368180 (2), 15538745 (1) (see all 8)
    osteomalacia 36.6 4 16691293 (3), 15630458 (1)
    breast cancer 29.8 14 19667160 (2), 19570947 (2), 15225785 (1), 15863722 (1) (see all 8)
    cancer 28.4 22 19570947 (3), 16680461 (2), 16180015 (1), 17507873 (1) (see all 13)
    colon carcinoma 24.2 3 12027461 (2), 11467853 (1)
    colon cancer 18.7 2 11467853 (2)
    tumors 16.5 17 16180015 (4), 14585316 (1), 17875655 (1), 12899539 (1) (see all 14)
    myeloid leukemia 14 2 10410379 (1), 16457885 (1)

    Genetic Association Database (GAD): CYP24A1
    Human Genome Epidemiology (HuGE) Navigator: CYP24A1 (31 documents)

    Export disorders for CYP24A1 gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    PubMed articles for CYP24A1 gene, integrated from 9 sources (see all 259) (see top 10):
    (articles sorted by number of sources associating them with CYP24A1)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Metabolism of vitamin D3 by cytochromes P450. (PubMed id 15574355)2, 7, 9 Sakaki T.... Inouye K. (2005)
    2. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2. (PubMed id 16516540)1, 7, 9 Masuda S....Jones G. (2006)
    3. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. (PubMed id 17606874)1, 4, 9 Bailey R....Todd J.A. (2007)
    4. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. (PubMed id 16600026)1, 4, 9 Wjst M....Andre E. (2006)
    5. Human 25-hydroxyvitamin D 24-hydroxylase cytochrome P450 subunit maps to a different chromosomal location than that of pseudovitamin D- deficient rickets. (PubMed id 8266831)1, 2, 9 Labuda M.... Glorieux F.H. (1993)
    6. Vitamin D pathway gene variants and prostate cancer r isk. (PubMed id 19454612)1, 4, 9 Holt S.K....Stanford J.L. (2009)
    7. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. (PubMed id 19255064)1, 4, 9 Ahn J....Hayes R.B. (2009)
    8. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. (PubMed id 17244366)1, 4, 9 McCullough M.L....Calle E.E. (2007)
    9. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. (PubMed id 21675912)1, 2 Schlingmann K.P.... Konrad M. (2011)
    10. Genetic risk and a primary role for cell-mediated immu ne mechanisms in multiple sclerosis. (PubMed id 21833088)1, 4  ....Compston A. (2011)
    11. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. (PubMed id 20847308)1, 4 Shen H....Mitchell B.D. (2010)
    12. Genetic susceptibility to distinct bladder cancer sub phenotypes. (PubMed id 19692168)1, 4 Guey L.T....Malats N. (2010)
    13. Vitamin D pathway gene variants and prostate cancer p rognosis. (PubMed id 20687218)1, 4 Holt S.K....Stanford J.L. (2010)
    14. A Large-scale genetic association study of esophageal adenocarcinoma risk. (PubMed id 20453000)1, 4 Liu C.Y....Christiani D.C. (2010)
    15. Genetic variants in nuclear-encoded mitochondrial gen es influence AIDS progression. (PubMed id 20877624)1, 4 Hendrickson S.L....O'Brien S.J. (2010)
    16. Infantile hypercalcemia and hypercalciuria: new insig hts into a vitamin D-dependent mechanism and response to ketoconazole treatment . (PubMed id 20394945)1, 4 Nguyen M....Garabedian M. (2010)
    17. Variation at the NFATC2 locus increases the risk of t hiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipr il and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)1, 4 Bailey S.D....Anand S. (2010)
    18. Common genetic determinants of vitamin D insufficienc y: a genome-wide association study. (PubMed id 20541252)1, 4 Wang T.J....Spector T.D. (2010)
    19. Polymorphisms in vitamin D metabolism related genes a nd risk of multiple sclerosis. (PubMed id 20007432)1, 4 Simon K.C....Ascherio A. (2010)
    20. Genetic variation in CYP27B1 is associated with conge stive heart failure in patients with hypertension. (PubMed id 19891555)1, 4 Wilke R.A....McCarty C.A. (2009)
    21. Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects. (PubMed id 19343046)1, 4 Saito A....Kamatani N. (2009)
    22. Single and multigenic analysis of the association bet ween variants in 12 steroid hormone metabolism genes and risk of prostate cance r. (PubMed id 19505920)1, 4 Beuten J....Leach R.J. (2009)
    23. PTEN identified as important risk factor of chronic o bstructive pulmonary disease. (PubMed id 19625176)1, 4 Hosgood H.D....Lan Q. (2009)
    24. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. (PubMed id 19170196)1, 4 Shen M....Lan Q. (2009)
    25. Asthma and genes encoding components of the vitamin D pathway. (PubMed id 19852851)1, 4 BossAc Y....Laprise C. (2009)
    26. High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. (PubMed id 19453261)1, 4 Yerges L.M....Zmuda J.M. (2009)
    27. Vitamin D related genes, CYP24A1 and CYP27B1, and col on cancer risk. (PubMed id 19706847)1, 4 Dong L.M....Peters U. (2009)
    28. Genetic variation in calcium-sensing receptor and risk for colon cancer. (PubMed id 18843020)1, 4 Dong L.M....Peters U. (2008)
    29. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. (PubMed id 18676680)1, 4 Hosgood H.D....Lan Q. (2008)
    30. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. (PubMed id 17932346)1, 4 Holick C.N....Peters U. (2007)
    31. The DNA sequence and comparative analysis of human chromosome 20. (PubMed id 11780052)1, 2 Deloukas P....Rogers J. (2001)
    32. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. (PubMed id 7632726)1, 2 Chen K.-S. and DeLuca H.F. (1995)
    33. Isolation and expression of human 1,25-dihydroxyvitamin D3 24- hydroxylase cDNA. (PubMed id 8506296)1, 2 Chen K.-S.... Deluca H.F. (1993)
    34. CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines. (PubMed id 17368180)1, 9 Muindi J.R....Trump D.L. (2007)
    35. Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats. (PubMed id 16617161)1, 9 Hamamoto H....Sakaki T. (2006)
    36. CYP24 promoter activity is affected by mechanical stress and mitogen-activated protein kinase in MG63 osteoblast-like cells. (PubMed id 18467787)1, 9 Toyoshita Y....Yokoyama A. (2008)
    37. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. (PubMed id 16691293)1, 9 Zhou C....Thummel K.E. (2006)
    38. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. (PubMed id 16708384)1, 9 Parise R.A....Hershberger P.A. (2006)
    39. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. (PubMed id 14760115)1, 9 Mimori K....Mori M. (2004)
    40. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). (PubMed id 11686044)7, 9 Inouye K. and Sakaki T. (2001)
    41. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. (PubMed id 15788398)1, 9 Ren S.... Hewison M. (2005)
    42. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. (PubMed id 15630458)1, 9 Pascussi J.M....Vilarem M.J. (2005)
    43. Vitamin D-24-hydroxylase in benign and malignant brea st tissue and cell lines. (PubMed id 19667160)1, 9 Fischer D....Thill M. (2009)
    44. Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. (PubMed id 17585873)1, 9 Moreau A....Pascussi J.M. (2007)
    45. Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE. (PubMed id 19237542)1, 9 Novakovic B....Saffery R. (2009)
    46. Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone. (PubMed id 17646648)1, 9 Prosser D.E....Jones G. (2007)
    47. [Recent studies on vitamin D metabolizing enzymes] (PubMed id 16816472)7, 9 Sakaki T. (2006)
    48. HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24. (PubMed id 16457885)1, 9 Ikezoe T....Taguchi H. (2006)
    49. Transcriptional inhibition of CYP24 by genistein. (PubMed id 12485911)1, 9 Farhan H. and Cross H.S. (2002)
    50. The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. (PubMed id 19901270)1, 9 HorvA!th H.C....KA!llay E. (2010)
    51. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2. (PubMed id 19097033)1, 9 Cui M....Fleet J.C. (2009)
    52. CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients. (PubMed id 17223345)1, 9 Ramos-Lopez E....Badenhoop K. (2007)
    53. RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. (PubMed id 17254772)1, 9 Anderson P.H....Morris H.A. (2007)
    54. Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts. (PubMed id 17079137)1, 9 Avila E....Larrea F. (2007)
    55. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs. (PubMed id 16886668)7, 9 Jones G....Mehta R. (2006)
    56. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. (PubMed id 15919092)1, 9 Vaisanen S....Carlberg C. (2005)
    57. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. (PubMed id 14665637)1, 9 Nguyen T.M....Garabedian M. (2004)
    58. Localization of the human vitamin D 24-hydroxylase gene (CYP24) to chromosome 20q13.2-->q13.3. (PubMed id 8440135)1, 9 Hahn C.N....Sutherland G.R. (1993)
    59. A role for the phosphatidylinositol 3-kinase--protein kinase C zeta--Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25 -hydroxyvitamin D3 24-hydroxylase gene in human kidney cells. (PubMed id 19922790)1, 9 Dwivedi P.P....Hii C.S. (2010)
    60. CYP27A1 and CYP24 expression as a function of malignant transformation in the colon. (PubMed id 17875655)1, 9 Matusiak D. and Benya R.V. (2007)
    61. Role of distal upstream sequence in vitamin D-induced expression of human CYP24 gene. (PubMed id 17475215)1, 9 Tashiro K....Ryoji M. (2007)
    62. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. (PubMed id 16720713)1, 9 Vigano P....Di Blasio A.M. (2006)
    63. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. (PubMed id 17023519)1, 9 van Driel M....van Leeuwen J.P. (2006)
    64. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine. (PubMed id 12641633)1, 9 Theodoropoulos C....Gascon-Barre M. (2003)
    65. Epigenetic regulation of the 1,25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1) in colon cancer cells. (PubMed id 22940288)1 Hobaus J....Kallay E. (2013)
    66. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. (PubMed id 23393347)1 Fuhrman B.J....Sigurdson A.J. (2013)
    67. Increased copy-number and not DNA hypomethylation caus es overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer. (PubMed id 23463632)1 Hobaus J....Kallay E. (2013)
    68. A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small -cell lung cancer. (PubMed id 23435876)1 Ramnath N....Trump D.L. (2013)
    69. CYP24A1 and CYP27B1 polymorphisms modulate vitamin D m etabolism in colon cancer cells. (PubMed id 23423976)1 Jacobs E.T....Jurutka P.W. (2013)
    70. 24-Hydroxylase in cancer: impact on vitamin D-based an ticancer therapeutics. (PubMed id 23059474)1 Luo W....Johnson C.S. (2013)
    71. Genetic sequence variants in vitamin D metabolism path way genes, serum vitamin D level and outcome in head and neck cancer patients. (PubMed id 23169318)1 Azad A.K....Xu W. (2013)
    72. Intravenous pamidronate in the treatment of severe idi opathic infantile hypercalcemia. (PubMed id 23485543)1 Skalova S....Schlingmann K.P. (2013)
    73. Marked increase of CYP24A1 mRNA level in hepatocellula r carcinoma cell lines following vitamin D administration. (PubMed id 23155244)1 Horvath E....Szalay F. (2012)
    74. Phorbol esters enhance 1a,25-dihydroxyvitamin D3-regul ated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-me diated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells. (PubMed id 22871965)1 Jiang Y. and Fleet J.C. (2012)
    75. Impaired vitamin D activation and association with CYP 24A1 haplotypes in differentiated thyroid carcinoma. (PubMed id 22690899)1 Penna-Martinez M....Badenhoop K. (2012)
    76. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tr omso Study. (PubMed id 22649517)1 Jorde R....Grimnes G. (2012)
    77. Astemizole synergizes calcitriol antiproliferative act ivity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast ca ncer therapy. (PubMed id 22984610)1 Garcia-Quiroz J....Diaz L. (2012)
    78. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorp hisms association with oral cancer risk and survival. (PubMed id 22612324)1 Zeljic K....Magic Z. (2012)
    79. Maternal vitamin D predominates over genetic factors i n determining neonatal circulating vitamin D concentrations. (PubMed id 22648713)1 Novakovic B....Saffery R. (2012)
    80. A local effect of CYP24 inhibition on lung tumor xenog raft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS a ssay. (PubMed id 22285938)1 Beumer J.H....Hershberger P.A. (2012)
    81. Altered expression of key players in vitamin D metabol ism and signaling in malignant and benign thyroid tumors. (PubMed id 22511602)1 Clinckspoor I....Decallonne B. (2012)
    82. Genome-wide association study identifies eight new sus ceptibility loci for atopic dermatitis in the Japanese population. (PubMed id 23042114)1 Hirota T....Tamari M. (2012)
    83. Expression of prostaglandin- and vitamin D-metabolisin g enzymes in benign and malignant breast cells. (PubMed id 22213328)1 Thill M....Cordes T. (2012)
    84. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. (PubMed id 21441443)1 Cooper J.D....Todd J.A. (2011)
    85. Bioengineering anabolic vitamin D-25-hydroxylase acti vity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V 391L mutation. (PubMed id 21697097)1 Kaufmann M....Jones G. (2011)
    86. Marked increase in CYP24A1 gene expression in human p apillary thyroid cancer. (PubMed id 21385079)1 Balla B....Lakatos P. (2011)
    87. Common genetic variants in the vitamin D pathway incl uding genome-wide associated variants are not associated with breast cancer ris k among Chinese women. (PubMed id 21828234)1 Dorjgochoo T....Shu X.O. (2011)
    88. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. (PubMed id 21440908)1 Orton S.M....Ebers G.C. (2011)
    89. CYP24A1 is an independent prognostic marker of surviv al in patients with lung adenocarcinoma. (PubMed id 21169243)1 Chen G....Ramnath N. (2011)
    90. Cytochromes P450 are essential players in the vitamin D signaling system. (PubMed id 20619365)7 Schuster I. (2011)
    91. Differential vitamin D 24-hydroxylase/CYP24A1 gene pr omoter methylation in endothelium from benign and malignant human prostate. (PubMed id 21725204)1 Deeb K.K....Trump D.L. (2011)
    92. Systematic and quantitative assessment of the ubiquiti n-modified proteome. (PubMed id 21906983)1 Kim W....Gygi S.P. (2011)
    93. The SH3 domain of postsynaptic density 95 mediates inf lammatory pain through phosphatidylinositol-3-kinase recruitment. (PubMed id 20467438)1 Arbuckle M.I....Grant S.G. (2010)
    94. CYP24A1 splice variants--implications for the antitum origenic actions of 1,25-(OH)2D3 in colorectal cancer. (PubMed id 20398751)1 HorvA!th H.C....Kallay E. (2010)
    95. High-density polymorphisms analysis of 23 candidate g enes for association with bone mineral density. (PubMed id 20654748)1 Giroux S....Rousseau F. (2010)
    96. Alterations in Vitamin D signalling and metabolic pat hways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 express ion in benign and malignant breast lesions. (PubMed id 20831823)1 Lopes N....Schmitt F. (2010)
    97. Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney. (PubMed id 19920212)7 Dunbar D.R....Bailey M.A. (2010)
    98. Expression of vitamin D receptor (VDR), cyclooxygenas e-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and m alignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostagla ndin E2 (PGE2) serum level in ovarian cancer patients. (PubMed id 20304053)1 Thill M....Becker S. (2010)
    99. The number of vitamin D receptor binding sites define s the different vitamin D responsiveness of the CYP24 gene in malignant and nor mal mammary cells. (PubMed id 20460683)1 Matilainen J.M....VAoisAonen S. (2010)
    100. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. (PubMed id 20809279)1 Bu F.X....Zhao L.J. (2010)
    101. Systematic characterisation of the rat and human CYP2 4A1 promoter. (PubMed id 20450955)1 Kumar R....Callen D.F. (2010)
    102. Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation. (PubMed id 21085059)4 Israni A....Oetting W.S. (2010)
    103. CYP24A1 inhibition enhances the antitumor activity of calcitriol. (PubMed id 20591973)1 Muindi J.R....Johnson C.S. (2010)
    104. Epigenetic regulation of vitamin D converting enzymes . (PubMed id 20304056)1 Wjst M....Pukelsheim K. (2010)
    105. Epigenetic silencing of CYP24 in the tumor microenvir onment. (PubMed id 20304059)1 Johnson C.S....Trump D.L. (2010)
    106. Epigenetic regulation of vitamin D 24-hydroxylase/CYP 24A1 in human prostate cancer. (PubMed id 20587525)1 Luo W....Trump D.L. (2010)
    107. SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. (PubMed id 19934256)7 Preissner S....Preissner R. (2010)
    108. Gene-centric association signals for lipids and apoli poproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)1 Talmud P.J.... . (2009)
    109. Metabolism of 1alpha,25-dihydroxyvitamin D2 by human CYP24A1. (PubMed id 19393625)1 Urushino N....Sakaki T. (2009)
    110. A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. (PubMed id 18824104)1 Roff A. and Wilson R.T. (2008)
    111. Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. (PubMed id 17426122)1 Turunen M.M....Vaisanen S. (2007)
    112. Vitamin D. (PubMed id 15951480)1 Dusso A.S....Slatopolsky E. (2005)
    113. Paricalcitol: a review of its use in the management o f secondary hyperparathyroidism. (PubMed id 15733015)7 Robinson D.M. and Scott L.J. (2005)
    114. Metabolism of 2 alpha-propoxy-1 alpha,25-dihydroxyvit amin D3 and 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1. (PubMed id 15764712)7 Abe D....Inouye K. (2005)
    115. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. (PubMed id 15128046)1 Nelson D.R....Nebert D.W. (2004)
    116. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. (PubMed id 15146197)1 Brandenberger R.... Stanton L.W. (2004)
    117. Metabolism of A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 by CYP24A1. (PubMed id 15358094)1 Kusudo T....Inouye K. (2004)
    118. Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1. (PubMed id 15078099)1 Sawada N....Inouye K. (2004)
    119. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. (PubMed id 15583024)1 Payne A.H. and Hales D.B. (2004)
    120. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)2 Gerhard D.S....Malek J. (2004)
    121. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. (PubMed id 12855575)1 Fritsche J....Kreutz M. (2003)
    122. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)1 Strausberg R.L....Marra M.A. (2002)
    123. Newly established assay method for 25-hydroxyvitamin D3 24-hydroxylase revealed much lower Km for 25-hydroxyvitamin D3 than for 1alpha,25-dihydroxyvitamin D3. (PubMed id 11149490)1 Taniguchi T....Setoguchi T. (2001)
    124. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. (PubMed id 10218951)1 Bland R....Hewison M. (1999)
    125. Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism. (PubMed id 7595086)1 Okuda K....Ohyama Y. (1995)
    126. Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes. (PubMed id 7938037)1 Chen M.L....Holick M.F. (1994)
    127. Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. (PubMed id 7829101)1 Robertson N.G....Morton C.C. (1994)
    128. Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. (PubMed id 19570947)9 Komagata S....Yokoi T. (2009)
    129. Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation. (PubMed id 18981260)9 Konno Y....Negishi M. (2009)
    130. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1. (PubMed id 15488475)9 Astecker N....Reddy G.S. (2004)
    131. Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. (PubMed id 9681485)9 Armbrecht H.J....Kumar V.B. (1998)
    132. Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats. (PubMed id 12787875)9 Sakaki T....Inouye K. (2003)
    133. Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism. (PubMed id 12899522)9 Schuster I....Vorisek G. (2003)
    134. Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes. (PubMed id 11179754)9 Schuster I....Vorisek G. (2001)
    135. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site. (PubMed id 15836435)9 Nutchey B.K....Hii C.S. (2005)
    136. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. (PubMed id 11012668)9 Sakaki T....Inouye K. (2000)
    137. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction. (PubMed id 12914530)9 Anderson P.H....Morris H.A. (2003)
    138. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. (PubMed id 19244278)9 Matsunawa M....Makishima M. (2009)
    139. Homology model of 1alpha,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): active site architecture and ligand binding. (PubMed id 17240137)9 Gomaa M.S....Brancale A. (2007)
    140. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells. (PubMed id 17182978)9 Lechner D....Cross H.S. (2007)
    141. Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies. (PubMed id 17224124)9 Masuda S....Jones G. (2007)
    142. Expression of VDR and CYP24A1 mRNA in human tumors. (PubMed id 16180015)9 Anderson M.G....Wu-Wong J.R. (2006)
    143. QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells. (PubMed id 17121927)9 Sundaram S....Gewirtz D.A. (2006)
    144. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. (PubMed id 15647825)9 Kim S....Pike J.W. (2005)
    145. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. (PubMed id 15225756)9 Anderson P.H....Morris H.A. (2004)
    146. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. (PubMed id 15113973)9 Cross H.S....Armbrecht H.J. (2004)
    147. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells. (PubMed id 14648702)9 Miettinen S....Ylikomi T. (2004)
    148. Extensive methylation of CpG island of CYP24 gene in osteoblastic ROS17/2.8 cells. (PubMed id 12903199)9 Ohyama Y....Ide H. (2002)
    149. Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3. (PubMed id 9165006)9 Akeno N....Horiuchi N. (1997)
    150. Molecular cloning of 25-hydroxyvitamin D-3 24-hydroxylase (Cyp-24) from mouse kidney: its inducibility by vitamin D-3. (PubMed id 7578252)9 Itoh S....Mimura T. (1995)
    151. Increase of renal 25-hydroxyvitamin D3-24-hydroxylase activity and its messenger ribonucleic acid level in 1 alpha-hydroxyvitamin D3-administered rats: possibility of the presence of two forms of 24-hydroxylase. (PubMed id 8410379)9 Akeno N....Horiuchi N. (1993)
    152. Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients. (PubMed id 16680461)9 Muindi J.R....Trump D.L. (2007)
    153. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. (PubMed id 16753019)9 Nguyen M....Garabedian M. (2006)
    154. Selective inhibition of vitamin D hydroxylases in human keratinocytes. (PubMed id 11179750)9 Schuster I....Vorisek G. (2001)
    155. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24. (PubMed id 11197067)9 Miyahara T....Nemoto N. (2000)
    156. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. (PubMed id 10385427)9 Jones G....Petkovich M. (1999)
    157. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. (PubMed id 17172823)9 Reichrath J....Seifert M. (2007)
    158. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. (PubMed id 17368191)9 Chung I....Trump D.L. (2007)
    159. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. (PubMed id 17395559)9 Atkins G.J....Morris H.A. (2007)
    160. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. (PubMed id 17235240)9 Koynova D.K....Gruis N.A. (2007)
    161. Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity. (PubMed id 18089708)9 Tan J....Hii C.S. (2007)
    162. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. (PubMed id 18290716)9 Adams J.S....Hewison M. (2007)
    163. Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation. (PubMed id 16824767)9 Vantieghem K....Segaert S. (2006)
    164. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. (PubMed id 16061850)9 Diesel B....Meese E. (2005)
    165. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells. (PubMed id 15860259)9 Khorchide M....Cross H.S. (2005)
    166. Using chromatin immunoprecipitation to monitor 1alpha,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter. (PubMed id 15225785)9 Vaisanen S....Carlberg C. (2004)
    167. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro. (PubMed id 15225804)9 Seifert M....Reichrath J. (2004)
    168. Analysis of the vitamin D system in basal cell carcinomas (BCCs). (PubMed id 15077124)9 Mitschele T....Reichrath J. (2004)
    169. Characterization of vitamin D-mediated induction of the CYP 24 transcription. (PubMed id 15489002)9 Tashiro K....Ryoji M. (2004)
    170. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. (PubMed id 12899526)9 Friedrich M....Reichrath J. (2003)
    171. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. (PubMed id 12504896)9 Armbrecht H.J....Boltz M.A. (2003)
    172. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). (PubMed id 12027461)9 Bareis P....Cross H.S. (2002)
    173. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. (PubMed id 11467853)9 Bareis P....Peterlik M. (2001)
    174. Prostaglandin E2 regulates vitamin D receptor expression, vitamin D-24-hydroxylase activity and cell proliferation in an adherent human myeloid leukemia cell line (Ad-HL60). (PubMed id 10410379)9 Smith S.J....Mawer E.B. (1999)
    175. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients. (PubMed id 10340962)9 Smith S.J....Mawer E.B. (1999)
    176. Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolism. (PubMed id 7622489)9 Dilworth F.J....Jones G. (1995)
    177. 20,23-dihydroxyvitamin D3, novel P450scc product, sti mulates differentiation and inhibits proliferation and NF-kappaB activity in hu man keratinocytes. (PubMed id 20020487)9 Janjetovic Z....Slominski A.T. (2010)
    178. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha, 25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate c ancer. (PubMed id 19667147)9 Flanagan J.N....Chen T.C. (2009)
    179. Characterization of the vitamin D endocrine system in human sebocytes in vitro. (PubMed id 19027855)9 KrAomer C....Reichrath J. (2009)
    180. Expression of 25-hydroxyvitamin D3-24-hydroxylase in benign and malignant ovarian cell lines and tissue. (PubMed id 19667159)9 Fischer D....Thill M. (2009)
    181. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. (PubMed id 17029768)9 Lechner D....Cross H.S. (2007)
    182. Metabolism of vitamin D3 in the placental tissue of n ormal and preeclampsia complicated pregnancies and premature births. (PubMed id 17629157)9 Fischer D....Friedrich M. (2007)
    183. Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3. (PubMed id 17693608)9 Chun R.F....Adams J.S. (2007)
    184. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. (PubMed id 16207822)9 Xu Y....Thummel K.E. (2006)
    185. Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. (PubMed id 16886669)9 Lechner D....Cross H.S. (2006)
    186. UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor. (PubMed id 16598763)9 Vantieghem K....Segaert S. (2006)
    187. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. (PubMed id 15955619)9 Swami S....Feldman D. (2005)
    188. The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention. (PubMed id 16081282)9 Cross H.S....Kallay E. (2005)
    189. Analysis of the vitamin D system in cutaneous squamous cell carcinomas. (PubMed id 14984574)9 Reichrath J....Holick M.F. (2004)
    190. Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives. (PubMed id 15482941)9 Yee S.W. and Simons C. (2004)
    191. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. (PubMed id 12270218)9 Farhan H....Cross H.S. (2002)
    192. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. (PubMed id 9687155)9 Dwivedi P.P....May B.K. (1998)
    193. Modulation of the bovine innate immune response by pr oduction of 1alpha,25-dihydroxyvitamin D(3) in bovine monocytes. (PubMed id 20172224)9 Nelson C.D....Lippolis J.D. (2010)
    194. Snail2 cooperates with Snail1 in the repression of vi tamin D receptor in colon cancer. (PubMed id 19502595)9 Larriba M.J....MuA+oz A. (2009)
    195. Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption. (PubMed id 19779013)9 Balesaria S....Walters J.R. (2009)
    196. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. (PubMed id 19667164)9 Vieth R. (2009)
    197. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. (PubMed id 18368131)9 Zbytek B....Slominski A.T. (2008)
    198. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. (PubMed id 18180267)9 Ishizawa M....Makishima M. (2008)
    199. Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. (PubMed id 18351578)9 Landriscina M....Ranieri E. (2008)
    200. Nutritional calcium modulates colonic expression of vitamin D receptor and pregnane X receptor target genes. (PubMed id 18327873)9 Nittke T....Cross H.S. (2008)
    201. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. (PubMed id 18651709)9 Heine G....Worm M. (2008)
    202. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. (PubMed id 17913968)9 Agic A....Hornung D. (2007)
    203. Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy. (PubMed id 17323831)9 Weiher H. and Zwacka R.M. (2007)
    204. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. (PubMed id 17130524)9 Peng X....Mehta R.G. (2007)
    205. [The influence of isoflavonoids on the antitumor activity of vitamin D3] (PubMed id 17507873)9 Wietrzyk J. (2007)
    206. Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1. (PubMed id 17213017)9 Rennstam K....Isola J. (2007)
    207. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. (PubMed id 17143621)9 Lassmann S....Werner M. (2007)
    208. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor. (PubMed id 17520689)9 Garay E....Studzinski G.P. (2007)
    209. Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1. (PubMed id 17553915)9 Urushino N....Sakaki T. (2007)
    210. Wavelength-dependent induction of CYP24A1-mRNA after UVB-triggered calcitriol synthesis in cultured human keratinocytes. (PubMed id 16902422)9 Bar M....Meurer M. (2007)
    211. Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2. (PubMed id 16960876)9 Klopot A....Fleet J.C. (2007)
    212. Early lethality in Hyp mice with targeted deletion of Pth gene. (PubMed id 17615144)9 Bai X....Karaplis A.C. (2007)
    213. Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer. (PubMed id 17182827)9 Swami S....Feldman D. (2007)
    214. Vitamin D--metabolism in the human breast cancer cell line MCF-7. (PubMed id 16886688)9 Diesing D....Friedrich M. (2006)
    215. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. (PubMed id 17056796)9 Rowling M.J....Welsh J. (2006)
    216. Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite. (PubMed id 16930540)9 Gottfried E....Kreutz M. (2006)
    217. Androgen enhances the antiproliferative activity of v itamin D3 by suppressing 24-hydroxylase expression in LNCaP cells. (PubMed id 16524720)9 Lou Y.R. and Tuohimaa P. (2006)
    218. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells. (PubMed id 16371233)9 Wu-Wong J.R....Ma J. (2006)
    219. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. (PubMed id 16549446)9 Kemmis C.M....Welsh J. (2006)
    220. Vitamin D compounds: clinical development as cancer therapy and prevention agents. (PubMed id 16886663)9 Trump D.L....Johnson C.S. (2006)
    221. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. (PubMed id 16849588)9 Peng X....Mehta R.G. (2006)
    222. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. (PubMed id 15860548)9 Perakyla M....Carlberg C. (2005)
    223. 5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells. (PubMed id 15538745)9 Lou Y.R....Tuohimaa P. (2005)
    224. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter. (PubMed id 15863722)9 Sinkkonen L....Carlberg C. (2005)
    225. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. (PubMed id 15890193)9 Dunlop T.W....Carlberg C. (2005)
    226. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells. (PubMed id 15225757)9 Avila E....Larrea F. (2004)
    227. No evidence for amplification of 25-hydroxyvitamin D-1alpha-OHase (1alpha-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma (MM). (PubMed id 15225766)9 Reichrath J....Seifert M. (2004)
    228. Selective regulation of vitamin D receptor-responsive genes by TFIIH. (PubMed id 15494306)9 Drane P.... Egly J.-M. (2004)
    229. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells. (PubMed id 15223133)9 Ma J.F....Peehl D.M. (2004)
    230. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites. (PubMed id 15225744)9 Kamao M....Okano T. (2004)
    231. The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien. (PubMed id 15173382)9 Moehren U....Baniahmad A. (2004)
    232. Enzymes involved in the activation and inactivation of vitamin D. (PubMed id 15544953)9 Prosser D.E. and Jones G. (2004)
    233. Eight cytochrome P450s catalyze vitamin D metabolism. (PubMed id 15353333)9 Ohyama Y. and Yamasaki T. (2004)
    234. 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. (PubMed id 12796488)9 Yamamoto H....Pike J.W. (2003)
    235. Vitamin D analogs--drug design based on proteins involved in vitamin D signal transduction. (PubMed id 12570725)9 Masuda S. and Jones G. (2003)
    236. Regulation of extrarenal synthesis of 1,25-dihydroxyvitamin D3--relevance for colonic cancer prevention and therapy. (PubMed id 14585316)9 Cross H.S....Lechner D. (2003)
    237. Phytoestrogens and 17beta-estradiol influence vitamin D metabolism and receptor expression-relevance for colon cancer prevention. (PubMed id 12899537)9 Lechner D. and Cross H.S. (2003)
    238. Analysis of the vitamin D system in cutaneous malignancies. (PubMed id 12899528)9 Kamradt J....Reichrath J. (2003)
    239. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. (PubMed id 12732287)9 Farhan H....Cross H.S. (2003)
    240. Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. (PubMed id 12899539)9 Cross H.S....Manhardt T. (2003)
    241. Regulation of 1,25-dihydroxyvitamin d synthesis by intracellular vitamin d binding protein-1. (PubMed id 12239126)9 Wu S....Adams J.S. (2002)
    242. Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines. (PubMed id 12181175)9 Fleet J.C....Wood R.J. (2002)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section
    Free Text  

      Query String
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section
    Entrez Gene: 1591 HGNC: 2602 AceView: CYP24A1 Ensembl:ENSG00000019186 euGenes: HUgn1591
    ECgene: CYP24A1 Kegg: 1591 H-InvDB: CYP24A1

    (According to HUGE)
    About This Section

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL,
    Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot)
    About This Section
    PharmGKB entry for CYP24A1 Pharmacogenomics, SNPs, Pathways
    ATLAS Chromosomes in Cancer entry for CYP24A1 Genetics and Cytogenetics in Oncology and Haematology

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section
    Patent Information for CYP24A1 gene:
    Search GeneIP for patents involving CYP24A1

    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search

    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, SABiosciences, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Cloud-Clone Corp., Thermo Fisher Scientific, LSBio, Gene Editing from DNA2.0 and Sirion Biotech, Clones from EMD Millipore, OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Sirion Biotech, Cell lines from GenScript, and LifeMap BioReagents, PCR Arrays from SABiosciences, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, and/or Enzo Life Sciences, In Situ Hybridization Assays from
    Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory, genOway)
    About This Section

     Browse Small Molecules at EMD Millipore
     Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
     EMD Millipore Mono- and Polyclonal Antibodies for the study of CYP24A1
     Browse for Gene Knock-down Tools from EMD Millipore
     Browse Kits and Assays available from EMD Millipore
     Browse Purified and Recombinant Proteins at EMD Millipore
     EMD Millipore Custom Antibody & Bulk Services
     EMD Millipore Preclinical / Clinical Development Services
     EMD Millipore Immunoassay Services
     EMD Millipore Target Screening & Profiling Services

     Browse Antibodies   Browse Cell Culture Products  
     Browse ELISAs   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Kinase Activity Assays/Reagents  
     Browse ELISpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Multiplex/Array Assay Kits/Reagents  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Protease Activity Assays and Reagents   Browse Recombinant/Natural Proteins  
     Browse Stem Cell Products   Browse Tocris Biochemicals & Compounds  
     Browse cDNA Clones   Browse Proteome Profiler Antibody Arrays  
     OriGene Antibodies for CYP24A1   OriGene RNAi products in human, mouse, rat for CYP24A1  
     OriGene qPCR primer pairs and template standards for CYP24A1   Browse OriGene Protein Over-expression Lysates  
     OriGene Custom Mass Spec   OriGene clones in human, mouse for CYP24A1  
     OriGene qSTAR qPCR primer pairs in human, mouse for CYP24A1   Browse OriGene full length recombinant human proteins expressed in human HEK293 cells  
     OriGene ORF clones in mouse, rat for CYP24A1   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for CYP24A1   OriGene Custom Protein Services for CYP24A1  

     QIAGEN Custom miScript Target Protector blocks miRNA-binding site of in human, mouse, rat CYP24A1
     QIAGEN SeqTarget long-range PCR primers for resequencing CYP24A1
     QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat CYP24A1
     QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat CYP24A1
     QIAGEN QuantiFast Probe-based Assays in human, mouse, rat CYP24A1
     QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat CYP24A1
     GenScript Custom Purified and Recombinant Proteins Services for CYP24A1 GenScript cDNA clones with any tag delivered in your preferred vector for CYP24A1
     GenScript Custom Assay Services for CYP24A1 GenScript Custom Superior Antibodies Services for CYP24A1
     GenScript Custom overexpressing Cell Line Services for CYP24A1 CloneReady with Over 120,000 Genes
     Gene Synthesis: Any Gene in Any Vector Vector-based siRNA and miRNA, Ready for Transfection
     Gene Mutant Library, Variants up to 10^11 Plasmid Preparation
     Custom Peptide Services
     Search for Antibodies & Assays

     Regulatory tfbs in CYP24A1 promoter
     Search Chromatin IP Primers for CYP24A1
     RT2 qPCR Primer Assay in human, mouse, rat CYP24A1
     GNC Network for CYP24A1
     SABiosciences PCR Arrays including human, mouse, rat CYP24A1
     Search Tocris compounds for CYP24A1 (CP24A)
     Browse Sino Biological Proteins and Antibodies
     Browse Sino Biological Cell Lysates
     Browse Sino Biological cDNA Clones
     4000+ Proteins
     Search Sino Biological for antibodies, proteins & pathways
     Protein Production Services
     Transfection Reagents
     Protein A/G/L resins
     Isotyping reagents
     Search for proteins, assays, substrates, inhibitors & antibodies
     Novus Tissue Slides
     CYP24A1 antibodies
     CYP24A1 proteins
     Antibodies for CYP24A1
     See all of Abcam's Antibodies, Kits and Proteins for CYP24A1
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Browse ProSpec Recombinant Proteins

     Proteins for CYP24A1
     Antibodies for CYP24A1
     ELISAs for CYP24A1
     CLIAs for CYP24A1
     Search LifeMap BioReagents cell lines for CYP24A1
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for CYP24A1
     SwitchGear 3'UTR luciferase reporter plasmids for CYP24A1
     SwitchGear Promoter luciferase reporter plasmids for CYP24A1
     ThermoFisher Antibodies for CYP24A1
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat CYP24A1
     inGenious Targeting Laboratory - Custom generated mouse model solutions for CYP24A1
     inGenious Targeting Laboratory - Custom generated inducible mouse model solutions for CYP24A1
     lentivirus for stable overexpression of CYP24A1
     lentivirus expression plasmids for stable overexpression of CYP24A1
     adenovirus for overexpression of CYP24A1
     LSBio Antibodies in human, mouse, rat for CYP24A1
    Customized transgenic rodents for:
     Biomarker expression
     Off-target effect monitoring
     Translational medicine
     Tissue-specific gene expresssion
     Time-controlled gene expresssion
    GeneCards Homepage - Last full update: 23 Oct 2013 - Incrementals: 4 Nov 2013 , 7 Nov 2013 , 23 Jan 2014

    View Random Gene

    (GIFtS: 73)
    transforming growth factor, beta 1
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 6 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 

    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      CYP24A1 gene at Home site.
    hostname: index build: 106 solr: 1.4